Geron Corporation Company Profile (NASDAQ:GERN)

About Geron Corporation (NASDAQ:GERN)

Geron Corporation logoGeron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company is engaged in the development of therapeutic products for oncology. Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Janssen is engaged in the development of Imetelstat with two clinical trials, such as a Phase II trial in myelofibrosis (MF), referred to as IMbark, and a Phase II/III trial in myelodysplastic syndromes (MDS) referred to as IMerge. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the RNA template of telomerase, thereby directly inhibiting telomerase activity.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:GERN
  • CUSIP: 37416310
  • Web: www.geron.com
Capitalization:
  • Market Cap: $347.09 million
  • Outstanding Shares: 159,213,000
Average Prices:
  • 50 Day Moving Avg: $2.12
  • 200 Day Moving Avg: $2.47
  • 52 Week Range: $1.81 - $3.15
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -108.00
  • P/E Growth: -2.42
Sales & Book Value:
  • Annual Revenue: $5.91 million
  • Price / Sales: 58.19
  • Book Value: $0.71 per share
  • Price / Book: 3.04
Profitability:
  • EBIDTA: ($26,810,000.00)
  • Net Margins: -433.72%
  • Return on Equity: -21.30%
  • Return on Assets: -19.74%
Debt:
  • Current Ratio: 9.06%
  • Quick Ratio: 9.06%
Misc:
  • Average Volume: 1.09 million shs.
  • Beta: 2.63
  • Short Ratio: 39.11
 

Frequently Asked Questions for Geron Corporation (NASDAQ:GERN)

What is Geron Corporation's stock symbol?

Geron Corporation trades on the NASDAQ under the ticker symbol "GERN."

How were Geron Corporation's earnings last quarter?

Geron Corporation (NASDAQ:GERN) announced its earnings results on Wednesday, August, 9th. The company reported ($0.04) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.05) by $0.01. The business earned $0.17 million during the quarter, compared to the consensus estimate of $0.38 million. Geron Corporation had a negative net margin of 433.72% and a negative return on equity of 21.30%. The business's revenue for the quarter was down 19.0% on a year-over-year basis. During the same quarter last year, the firm earned ($0.05) earnings per share. View Geron Corporation's Earnings History.

When will Geron Corporation make its next earnings announcement?

Geron Corporation is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Geron Corporation.

Where is Geron Corporation's stock going? Where will Geron Corporation's stock price be in 2017?

4 analysts have issued twelve-month price objectives for Geron Corporation's stock. Their predictions range from $2.50 to $5.00. On average, they anticipate Geron Corporation's share price to reach $4.17 in the next year. View Analyst Ratings for Geron Corporation.

Are investors shorting Geron Corporation?

Geron Corporation saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 31,843,882 shares, an increase of 1.4% from the August 15th total of 31,401,742 shares. Based on an average trading volume of 957,094 shares, the days-to-cover ratio is presently 33.3 days. Currently, 20.1% of the shares of the company are short sold.

Who are some of Geron Corporation's key competitors?

Who are Geron Corporation's key executives?

Geron Corporation's management team includes the folowing people:

  • Hoyoung Huh Ph.D., Independent Chairman of the Board
  • John A. Scarlett M.D., President, Chief Executive Officer, Director
  • Olivia K. Bloom, Chief Financial Officer, Executive Vice President - Finance, Treasurer
  • Stephen N. Rosenfield J.D., Executive Vice President, General Counsel and Corporate Secretary
  • Andrew J. Grethlein Ph.D., Executive Vice President - Development and Technical Operations
  • Melissa A. Kelly Behrs, Executive Vice President - Business Development and Portfolio and Alliance Management
  • Susan M. Molineaux Ph.D., Director
  • Daniel M. Bradbury, Independent Director
  • Karin Eastham CPA, Independent Director
  • V. Bryan Lawlis Jr. Ph.D., Independent Director

Who owns Geron Corporation stock?

Geron Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (14.90%), Vanguard Group Inc. (4.65%), State Street Corp (3.22%), Northern Trust Corp (1.17%), State of New Jersey Common Pension Fund D (0.55%) and QS Investors LLC (0.51%). View Institutional Ownership Trends for Geron Corporation.

Who sold Geron Corporation stock? Who is selling Geron Corporation stock?

Geron Corporation's stock was sold by a variety of institutional investors in the last quarter, including Virtu KCG Holdings LLC, Goldman Sachs Group Inc., California State Teachers Retirement System, UBS Asset Management Americas Inc., Dimensional Fund Advisors LP, Bank of New York Mellon Corp, Janney Montgomery Scott LLC and Rhumbline Advisers. View Insider Buying and Selling for Geron Corporation.

Who bought Geron Corporation stock? Who is buying Geron Corporation stock?

Geron Corporation's stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Vanguard Group Inc., State of Wisconsin Investment Board, Cutler Group LP, Zacks Investment Management, Russell Investments Group Ltd., TIAA CREF Investment Management LLC and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Geron Corporation.

How do I buy Geron Corporation stock?

Shares of Geron Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Geron Corporation's stock price today?

One share of Geron Corporation stock can currently be purchased for approximately $2.16.


MarketBeat Community Rating for Geron Corporation (NASDAQ GERN)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  166 (Vote Outperform)
Underperform Votes:  128 (Vote Underperform)
Total Votes:  294
MarketBeat's community ratings are surveys of what our community members think about Geron Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Geron Corporation (NASDAQ:GERN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $4.17 (92.90% upside)

Analysts' Ratings History for Geron Corporation (NASDAQ:GERN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/4/2017FBR & CoReiterated RatingBuyMediumView Rating Details
4/12/2017Stifel NicolausReiterated RatingHold$2.50LowView Rating Details
4/12/2017Piper Jaffray CompaniesReiterated RatingOverweight$5.00LowView Rating Details
3/2/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
9/20/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$6.50N/AView Rating Details
12/7/2015Oppenheimer Holdings, Inc.Reiterated RatingBuy$5.50N/AView Rating Details
(Data available from 9/23/2015 forward)

Earnings

Earnings History for Geron Corporation (NASDAQ:GERN)
Earnings by Quarter for Geron Corporation (NASDAQ:GERN)
Earnings History by Quarter for Geron Corporation (NASDAQ GERN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017        
8/9/2017Q2 2017($0.05)($0.04)$0.38 million$0.17 millionViewN/AView Earnings Details
5/9/2017Q1 2017($0.05)($0.05)$0.27 million$0.54 millionViewN/AView Earnings Details
3/1/2017Q416($0.06)($0.05)$0.18 million$0.09 millionViewListenView Earnings Details
11/3/2016Q316($0.06)($0.02)$0.22 million$5.10 millionViewListenView Earnings Details
8/3/2016Q216($0.07)($0.05)$0.38 million$0.21 millionViewListenView Earnings Details
5/5/2016Q116($0.06)($0.06)$0.26 million$0.74 millionViewListenView Earnings Details
2/25/2016Q415($0.05)($0.05)$0.32 million$0.22 millionViewListenView Earnings Details
11/5/2015Q315$0.11$0.17$17.87 million$35.40 millionViewListenView Earnings Details
8/5/2015Q2 15($0.06)($0.05)$0.40 million$0.25 millionViewN/AView Earnings Details
4/30/2015Q1($0.06)($0.06)$0.32 million$0.54 millionViewN/AView Earnings Details
3/3/2015Q4$0.17($0.06)$35.35 million$0.18 millionViewListenView Earnings Details
11/5/2014Q314($0.06)($0.06)$0.28 million$0.16 millionViewN/AView Earnings Details
8/11/2014Q214($0.06)($0.06)$0.22 million$0.34 millionViewListenView Earnings Details
5/1/2014Q114($0.06)($0.06)$0.35 million$0.47 millionViewListenView Earnings Details
3/27/2014($0.06)($0.07)ViewN/AView Earnings Details
3/17/2014Q413($0.07)($0.07)$0.35 millionViewListenView Earnings Details
11/7/2013Q313($0.06)($0.06)$0.49 million$0.18 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.07)($0.07)$0.50 million$0.11 millionViewListenView Earnings Details
4/25/2013Q1 2013($0.08)($0.09)$0.71 million$0.77 millionViewListenView Earnings Details
3/12/2013Q4 2012($0.14)($0.12)$0.50 million$0.69 millionViewListenView Earnings Details
10/30/2012Q312($0.14)($0.13)$0.38 million$0.64 millionViewN/AView Earnings Details
7/31/2012($0.15)($0.14)ViewN/AView Earnings Details
5/2/2012($0.18)($0.15)ViewN/AView Earnings Details
11/3/2011($0.18)($0.16)ViewN/AView Earnings Details
7/28/2011($0.18)($0.17)ViewN/AView Earnings Details
4/27/2011($0.19)($0.20)ViewN/AView Earnings Details
2/24/2011($0.19)($0.39)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Geron Corporation (NASDAQ:GERN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.06)($0.06)($0.06)
Q4 20171($0.06)($0.06)($0.06)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Geron Corporation (NASDAQ:GERN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Geron Corporation (NASDAQ:GERN)
Insider Ownership Percentage: 7.10%
Institutional Ownership Percentage: 38.79%
Insider Trades by Quarter for Geron Corporation (NASDAQ:GERN)
Institutional Ownership by Quarter for Geron Corporation (NASDAQ:GERN)
Insider Trades by Quarter for Geron Corporation (NASDAQ:GERN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/29/2015Olivia Kyusuk BloomCFOSell2,380$3.84$9,139.20View SEC Filing  
3/18/2015Thomas HofstaetterDirectorSell70,000$4.10$287,000.00View SEC Filing  
5/29/2014Melissa Kelly BehrsEVPSell4,826$2.10$10,134.60View SEC Filing  
5/29/2014Olivia Kyusuk BloomCFOSell3,379$2.10$7,095.90View SEC Filing  
5/9/2014Daniel BradburyDirectorBuy142,776$1.75$249,858.00View SEC Filing  
4/1/2014Melissa Kelly BehrsEVPSell12,310$2.13$26,220.30View SEC Filing  
4/1/2014Olivia Kyusuk BloomCFOSell7,435$2.13$15,836.55View SEC Filing  
4/1/2013John A ScarlettCEOBuy50,000$1.03$51,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Geron Corporation (NASDAQ:GERN)
Latest Headlines for Geron Corporation (NASDAQ:GERN)
Source:
DateHeadline
americanbankingnews.com logoContrasting Geron Corporation (GERN) & Its Rivals
www.americanbankingnews.com - September 20 at 10:46 AM
globenewswire.com logoGeron to Present at the Cantor Fitzgerald Healthcare Conference - GlobeNewswire (press release)
globenewswire.com - September 20 at 12:05 AM
finance.yahoo.com logoGeron to Present at the Cantor Fitzgerald Healthcare Conference
finance.yahoo.com - September 19 at 7:02 PM
finance.yahoo.com logoETFs with exposure to Geron Corp. : September 19, 2017
finance.yahoo.com - September 19 at 7:02 PM
finance.yahoo.com logoGeron Corp. :GERN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 6:34 PM
americanbankingnews.com logoGeron Corporation (GERN) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - September 13 at 4:48 AM
americanbankingnews.com logoGeron Corporation (GERN) Sees Significant Drop in Short Interest
www.americanbankingnews.com - August 27 at 4:28 AM
fool.com logo3 Top Biotech Stocks Under $5
www.fool.com - August 19 at 4:26 PM
americanbankingnews.com logoGeron Corporation (GERN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 19 at 7:24 AM
finance.yahoo.com logoGeron's (GERN) Imetelstat Progressing Well, Setbacks Concern - Yahoo Finance
finance.yahoo.com - August 16 at 12:40 AM
zacks.com logoGeron's (GERN) Imetelstat Progressing Well, Setbacks Concern
www.zacks.com - August 14 at 7:19 PM
americanbankingnews.com logoGeron Corporation (GERN) Announces Quarterly Earnings Results
www.americanbankingnews.com - August 11 at 9:38 PM
finance.yahoo.com logoGeron (GERN) Q2 Loss Narrows, Sales Miss Estimates, Stock Up
finance.yahoo.com - August 10 at 11:34 PM
rttnews.com logoEARNINGS SUMMARY: Details of Geron Corporation Q2 Earnings Report
www.rttnews.com - August 10 at 12:15 AM
nasdaq.com logoGeron Corporation Reports Second Quarter 2017 Financial Results ... - Nasdaq
www.nasdaq.com - August 9 at 7:13 PM
finance.yahoo.com logoGeron Corporation Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 9 at 7:13 PM
finance.yahoo.com logoGeron reports 2Q loss
finance.yahoo.com - August 9 at 7:13 PM
americanbankingnews.com logoGeron Corporation (GERN) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - August 7 at 10:48 AM
americanbankingnews.com logoGeron Corporation (NASDAQ:GERN) Downgraded by BidaskClub
www.americanbankingnews.com - August 5 at 2:58 PM
finance.yahoo.com logoGeron Corp. – Value Analysis (NASDAQ:GERN) : August 4, 2017
finance.yahoo.com - August 4 at 2:27 AM
finance.yahoo.com logoETFs with exposure to Geron Corp. : August 4, 2017
finance.yahoo.com - August 3 at 9:26 PM
finance.yahoo.com logoTuesday's Movers: Shopify Inc (US) (SHOP) Soars, Houston American Energy Corporation (HUSA) Skyrockets, Geron ... - Yahoo News
finance.yahoo.com - August 2 at 3:18 PM
seekingalpha.com logoGeron: SLOW Progress - Seeking Alpha
seekingalpha.com - August 2 at 3:18 PM
streetinsider.com logoGeron Corp (GERN) Provides Updates for Imetelstat Clinical Development
www.streetinsider.com - August 2 at 5:35 AM
finance.yahoo.com logoGeron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : August 1, 2017
finance.yahoo.com - August 1 at 7:33 PM
finance.yahoo.com logoHere's Why Geron Corporation Fell as Much as 16.6% Today
finance.yahoo.com - August 1 at 7:33 PM
fool.com logoHere's Why Geron Corporation Fell as Much as 16.6% Today
www.fool.com - August 1 at 2:19 PM
seekingalpha.com logoGeron down 13% in early trading on extended timeline for imetelstat study, risk that Janssen will bail
seekingalpha.com - August 1 at 10:30 AM
globenewswire.com logoGeron Announces Updates to Imetelstat Clinical Development - GlobeNewswire (press release)
globenewswire.com - July 31 at 11:38 PM
finance.yahoo.com logoGeron Announces Updates to Imetelstat Clinical Development
finance.yahoo.com - July 31 at 11:38 PM
finance.yahoo.com logo3 Stocks Under $5 That Could Make You Rich
finance.yahoo.com - July 31 at 3:47 AM
thestreet.com logoCommit To Buy Geron Corp. At $2, Earn 12.8% Annualized Using Options
www.thestreet.com - July 27 at 12:35 AM
nasdaq.com logoWhat's in the Cards for Geron (GERN) this Earnings Season? - Nasdaq
www.nasdaq.com - July 25 at 7:17 PM
americanbankingnews.com logoGeron Corporation (NASDAQ:GERN) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - July 25 at 8:42 AM
prnewswire.com logoTechnical Snapshots for These Biotech Stocks -- Exelixis, Celldex Therapeutics, Clovis Oncology, and Geron - PR Newswire (press release)
www.prnewswire.com - July 24 at 9:12 AM
finance.yahoo.com logoGeron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : July 21, 2017
finance.yahoo.com - July 22 at 12:08 AM
americanbankingnews.com logoZacks Investment Research Downgrades Geron Corporation (NASDAQ:GERN) to Hold
www.americanbankingnews.com - July 11 at 6:02 PM
finance.yahoo.com logoETFs with exposure to Geron Corp. : July 7, 2017
finance.yahoo.com - July 8 at 11:03 AM
zacks.com logoWhy Geron (GERN) Might Be a Diamond in the Rough
www.zacks.com - July 5 at 7:38 PM
zacks.com logoGeron Stock Up Almost 40% So Far This Year After '16 Decline
www.zacks.com - July 5 at 7:37 AM
americanbankingnews.com logoGeron Corporation (GERN) Short Interest Update
www.americanbankingnews.com - June 30 at 7:06 AM
seekingalpha.com logoA Look At The Competition Geron Could Face In Myelodysplastic Syndromes
seekingalpha.com - June 29 at 10:41 PM
seekingalpha.com logoGeron: Wishing And Hoping - Seeking Alpha
seekingalpha.com - June 29 at 4:44 AM
americanbankingnews.com logoGeron Corporation (GERN) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - June 28 at 8:20 AM
finance.yahoo.com logoETFs with exposure to Geron Corp. : June 26, 2017
finance.yahoo.com - June 26 at 6:57 PM
finance.yahoo.com logoHere's Why Geron (GERN) is a Good Stock to Invest in Now - Yahoo Finance
finance.yahoo.com - June 23 at 3:27 PM
finance.yahoo.com logoToday's Research Reports on Stocks to Watch: Geron Corporation and Teva Pharmaceutical
finance.yahoo.com - June 23 at 3:27 PM
zacks.com logoHere's Why Geron (GERN) is a Good Stock to Invest in Now
www.zacks.com - June 23 at 1:34 AM
americanbankingnews.com logo Brokerages Expect Geron Corporation (GERN) Will Post Quarterly Sales of $460,000.00
www.americanbankingnews.com - June 22 at 11:38 AM
americanbankingnews.com logoZacks: Analysts Expect Geron Corporation (GERN) to Announce -$0.05 EPS
www.americanbankingnews.com - June 20 at 8:14 AM

Social

Chart

Geron Corporation (GERN) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff